Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

OpenCell BioMed Announces Completion Of Phase-2 Testing Of Its TI FOAM Dental Implant Design

OpenCell BioMed Inc. announced that it has completed phase-2 fatigue testing on its proprietary TI FOAM dental implant design in conjunction with the Canadian National Research Council (CNRC). The CNRC phase-2 report concluded: 1. All implants were easily implanted. 2. No titanium particle debris was observed after implant retrieval, suggesting that the titanium foam has sufficient abrasion resistance, at least for the conditions used in this study. 3. The initial stability of all implants was good. However, the torque required to unscrew the implants was slightly larger for the implants without foam. This finding was associated with the enlargement of the holes caused by the abrasion of the bone by the foam. A modification of the design was proposed to address this issue and increase the contact area between the implant and the crestal bone. 4. Important amount of bone interlocked in the foam was observed after implantation. It is believed that this will provide good implant stability after bone remodeling. 5. The fatigue limits of the implants with and without foam were similar. This is a positive finding considering the results reported in the literature on the effect of porous coating on the fatigue of Ti6Al4V implants. TI FOAM is used as the bone to implant interface enabling dental implant systems. It has greater short and long term stability with minimally invasive techniques compared to traditional dental implant systems.